Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 204

1.

Glioblastoma cancer stem cells: role of the microenvironment and therapeutic targeting.

Persano L, Rampazzo E, Basso G, Viola G.

Biochem Pharmacol. 2013 Mar 1;85(5):612-22. doi: 10.1016/j.bcp.2012.10.001. Epub 2012 Oct 11. Review.

PMID:
23063412
2.

Human glioblastoma stem-like cells are more sensitive to allogeneic NK and T cell-mediated killing compared with serum-cultured glioblastoma cells.

Avril T, Vauleon E, Hamlat A, Saikali S, Etcheverry A, Delmas C, Diabira S, Mosser J, Quillien V.

Brain Pathol. 2012 Mar;22(2):159-74. doi: 10.1111/j.1750-3639.2011.00515.x. Epub 2011 Sep 16.

PMID:
21790828
3.

The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence.

Auffinger B, Spencer D, Pytel P, Ahmed AU, Lesniak MS.

Expert Rev Neurother. 2015;15(7):741-52. doi: 10.1586/14737175.2015.1051968. Epub 2015 May 31. Review.

4.

Gliomagenesis: a game played by few players or a team effort?

Mazzoleni S, Galli R.

Front Biosci (Elite Ed). 2012 Jan 1;4:205-13. Review.

PMID:
22201865
5.

STAT3 as a Therapeutic Target for Glioblastoma.

Liu Y, Li C, Lin J.

Anticancer Agents Med Chem. 2010 Sep;10(7):512-9. Review.

PMID:
20879983
6.

Chemoresistance in high-grade gliomas: relevance of adenosine signalling in stem-like cells of glioblastoma multiforme.

Garrido W, Rocha JD, Jaramillo C, Fernandez K, Oyarzun C, San Martin R, Quezada C.

Curr Drug Targets. 2014;15(10):931-42. Review.

PMID:
25174341
7.

Emerging therapeutic targets and agents for glioblastoma migrating cells.

Di C, Mattox AK, Harward S, Adamson C.

Anticancer Agents Med Chem. 2010 Sep;10(7):543-55. Review.

PMID:
20950259
8.

Targeting role of glioma stem cells for glioblastoma multiforme.

Zhang X, Zhang W, Mao XG, Zhen HN, Cao WD, Hu SJ.

Curr Med Chem. 2013;20(15):1974-84. Review.

PMID:
23317162
9.

The role of basic fibroblast growth factor in glioblastoma multiforme and glioblastoma stem cells and in their in vitro culture.

Haley EM, Kim Y.

Cancer Lett. 2014 Apr 28;346(1):1-5. doi: 10.1016/j.canlet.2013.12.003. Epub 2013 Dec 11. Review.

10.

Therapeutic strategies targeting glioblastoma stem cells.

Carrasco-Garcia E, Sampron N, Aldaz P, Arrizabalaga O, Villanua J, Barrena C, Ruiz I, Arrazola M, Lawrie C, Matheu A.

Recent Pat Anticancer Drug Discov. 2013 Sep;8(3):216-27. Review.

PMID:
23607282
11.

Targeting glioblastoma stem cells: cell surface markers.

He J, Liu Y, Lubman DM.

Curr Med Chem. 2012;19(35):6050-5. Review.

PMID:
22963566
12.

Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine.

Kim SS, Harford JB, Pirollo KF, Chang EH.

Biochem Biophys Res Commun. 2015 Dec 18;468(3):485-9. doi: 10.1016/j.bbrc.2015.06.137. Epub 2015 Jun 24. Review.

13.

The three-layer concentric model of glioblastoma: cancer stem cells, microenvironmental regulation, and therapeutic implications.

Persano L, Rampazzo E, Della Puppa A, Pistollato F, Basso G.

ScientificWorldJournal. 2011;11:1829-41. doi: 10.1100/2011/736480. Epub 2011 Oct 23. Review.

14.

Immunotherapy targeting glioma stem cells--insights and perspectives.

Li Z, Lee JW, Mukherjee D, Ji J, Jeswani SP, Black KL, Yu JS.

Expert Opin Biol Ther. 2012 Feb;12(2):165-78. doi: 10.1517/14712598.2012.648180. Epub 2011 Dec 26. Review.

PMID:
22200324
15.

Imaging glioma initiation in vivo through a polished and reinforced thin-skull cranial window.

Zhang L, Lapierre A, Roy B, Lim M, Zhu J, Wang W, Sampson SB, Yun K, Lyons B, Li Y, Lin DT.

J Vis Exp. 2012 Nov 20;(69). pii: 4201. doi: 10.3791/4201.

16.

Frontiers in targeting glioma stem cells.

Frosina G.

Eur J Cancer. 2011 Mar;47(4):496-507. doi: 10.1016/j.ejca.2010.11.017. Epub 2010 Dec 22. Review.

PMID:
21185169
17.

Collateral damage control in cancer therapy: defining the stem identity in gliomas.

Hsieh D.

Curr Pharm Des. 2011;17(23):2370-85. Review.

PMID:
21827417
18.

The cancer stem cell niche(s): the crosstalk between glioma stem cells and their microenvironment.

Filatova A, Acker T, Garvalov BK.

Biochim Biophys Acta. 2013 Feb;1830(2):2496-508. doi: 10.1016/j.bbagen.2012.10.008. Epub 2012 Oct 16.

PMID:
23079585
19.

Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.

Ning S, Knox SJ.

Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):197-203.

PMID:
15337556
20.

Brain tumor stem cells as research and treatment targets.

Hide T, Takezaki T, Nakamura H, Kuratsu J, Kondo T.

Brain Tumor Pathol. 2008;25(2):67-72. doi: 10.1007/s10014-008-0237-5. Epub 2008 Nov 6. Review.

PMID:
18987831

Supplemental Content

Support Center